Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
fda
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
sanofi
alirocumab
alnylam pharmaceuticals
american society of clinical oncology (asco)
amgen
anti-inflammatory drugs
arcturus therapeutics
avrobio
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
crispr therapeutics
crispr-cas9
denali therapeutics
detroit blog main
detroit top stories
eidos therapeutics
estradiol
evolocumab
f-star gamma
food and drug administration
gene editing
genmab
ido inhibitors
inclisiran
incyte
What
cash
2
×
drug
2
×
acquire
agreed
ahead
ambien
american
annual
asco
attendees
attention
billion
biotech
brings
camp’s
cancer
chicago
cholesterol
city
clinical
combinations
community’s
company
compound
days
deal
expanding
fda
focus
home
key
kicks
medco
medicines
meeting
new
novartis
oncology
oncology’s
poised
Language
unset
Current search:
cash
×
drug
×
fda
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
